Biogen | Capital Ordinário



Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.77M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 1000 2024-12
Intra Cellular Therapies USD 11K 0 2024-12
Merck USD 1.79B 0 2024-12
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Sarepta Therapeutics USD 10K 0 2024-12
Teva Pharmaceutical Industries USD 58M 0 2024-09
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 100K 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Biogen Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.